Skip to main content
. 2018 Jun 15;13:92. doi: 10.1186/s13023-018-0826-2

Table 2.

Differential diagnosis of Pontocerebellar Hypoplasia (PCH)

Disease Distinctive features Gene(s) involved references
Congenital disorder of Glycosylation Ia (CDGIa) Clinical: neonatal onset multi organ failure, dysmorphic features, ataxia. Microcephaly.
MRI: global PCH with superimposed atrophy, supratentorial atrophy, ventriculomegaly, delayed myelinisation.
PMM2 [68, 69, 72]
CASK- related disorders Clinical: facial dysmorphism, sensorineural hearing loss, ophthalmologic abnormalities. Developmental progress in a subgroup of patients. No MND or chorea. Progressive microcephaly.
MRI: variable degree of PCH, equally affecting hemispheres and vermis. Cortical malformations can be present.
CASK [73-76]
Tubulin defects Clinical: DD, seizures. Progressive microcephaly. Optic atrophy in some cases.
MRI: cortical malformations (eg lissencephaly, polymicrogyria) with cerebellar hypoplasia and brainstem malformations.
TUBA1A, TUBB2B, TUBB3, TUBB5, TUBA8 [77-79]
RELN & VLDLR mutations Clinical: Severe DD, hypotonia, epilepsy, nystagmus. In VLDLR: non-progressive ataxia, quadrupedal gait.
MRI: lissencephaly, severe PCH and abnormal hippocampus, milder in VLDLR.
RELN, VLDLR [80-82]
α- dystroglycan related dystrophies (WWS, MEB, Fukuyama congenital muscular dystrophy) Clinical: severe DD, muscle weakness with increased CK, ophthalmologic abnormalities. WWS at the severest end of the spectrum.
MRI: wide spectrum of brain malformations including cobblestone lissencephaly, PCH, congenital hydrocephalus.
POMT1, POMT2, POMGnT1, LARGE, FKTN, FKRP, ISPD, FKR, FKRP [83, 84, 85]
X-linked Hoyeraal-Hreidarsson syndrome Clinical: IUGR, microcephaly, failure to thrive, progressive bone marrow failure, aplastic anemia, combined immunodeficiency, some symptoms of DC.
MRI: PCH, delayed myelinisation, focal high intensities in brainstem and thalamus, subcortical calcifications.
DKC1 [86-87]
Pediatric onset Spinocerebellar Ataxia Clinical: Ataxia, developmental progress, some cases with retinitis pigmentosa or cone-rod dystrophy.
MRI: (ponto) cerebellar hypoplasia/atrophy, no supratentorial atrophy.
ITPR1, ATXN7, ATXN2 [88-92]
Extreme prematurity (< 32 weeks) Clinical: motor and cognitive impairment of variable degree, autism spectrum disorders
MRI: PCH, signs of cerebellar or cerebral injury, eg hemorrhage. Non progressive.
n/a [95-97]

MND motor neuron degeneration, DD developmental delay, CK creatine kinase, WWS Walker-Warburg syndrome, MEB Musce Eye Brain disease, IUGR Intrauterine Growth Retardation, DC dyskeratosis congenita